Recruiting
Chemotherapy cardiotoxicity attenuation
RecruitingRegistered drugNo placebo
Early detection of heart damage using cardiac magnetic resonance imaging in cancer patients receiving doxorubicin, epirubicin, pixantrone and other anthracyclines
Registered drugNo placebo
- Disease:Chemotherapy cardiotoxicity attenuation
- Substances:Daunorubicin HydrochlorideDoxorubicin Hydrochloride+3
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Substances:Daunorubicin Hydrochloride
- Sponsor:Robert Bosch Gesellschaft fuer medizinische Forschung mbH


